Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study"

Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):e280-e281. doi: 10.1161/ATVBAHA.121.316224. Epub 2021 Apr 21.

Authors

Adrien Carmona¹, Benjamin Marchandot¹, Kensuke Matsushita^{1

2}, Olivier Morel^{1

2}

Affiliations

¹ Division of Cardiovascular Medicine, Strasbourg University Hospital, France (A.C., B.M., K.M., O.M.).
² French National Institute of Health and Medical Research, UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France (K.M., O.M.).

PMID: 33881925
DOI: 10.1161/ATVBAHA.121.316224

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Cohort Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
SARS-CoV-2

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors